Case ID: f-appx_628/html/0764-02.html
Source: Caselaw Access Project
Author: {"author": "PER CURIAM.", "license": "Public Domain", "url": "https://static.case.law/"}
Date Created: 2024-08-24T03:29:51.129683

PFIZER INC., Pharmacia & Upjohn Company, Pharmacia & Upjohn Company LLC, Sugen, Inc., C.P. Pharmaceuticals International C.V., Pfizer Pharmaceuticals LLC, PF Prism C.V., Plaintiffs-Appellees v. MYLAN PHARMACEUTICALS INC., Defendant-Appellant.
    No. 2015-1131.
    United States Court of Appeals, Federal Circuit.
    Jan. 13, 2016.
    Thomas H.L. Selby, Williams & Connolly LLP, Washington, DC, argued for plaintiffs-appellees. Also represented by Stanley E. Fisher, Jessamyn Sheli Berniker, Sara Kaiser Creighton.
    Douglas H. Carsten, Wilson, Sonsini, Goodrich & Rosati, PC, San Diego, CA, argued for defendant-appellant. Also represented by Peter Soo Kang; Katherine Hasper, Palo Alto, CA; Robert Delafield, Austin, TX.
    
      DYK, WALLACH, and HUGHES, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.